|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 267/14 | |
| C07D 413/04 | |||
| C07D 413/12 | |||
| C07D 413/14 | |||
| C07D 498/04 | |||
| A61K 31/553 |
| (11) | Patento numeris | 2726469 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12735400.9 |
| Europos patento paraiškos padavimo data | 2012-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/045021 |
| Data | 2012-06-29 |
| (87) | Numeris | WO 2013/006463 |
| Data | 2013-01-10 |
| (30) | Numeris | Data | Šalis |
| 201161503980 P | 2011-07-01 | US |
| (72) |
CORKEY, Britton, Kenneth, US
ELZEIN, Elfatih, US
JIANG, Robert, H., US
KALLA, Rao, V., US
KOLTUN, Dmitry, US
LI, Xiaofen, US
MARTINEZ, Ruben, US
PARKHILL, Eric, Q., US
PERRY, Thao, US
ZABLOCKI, Jeff, US
VENKATARAMANI, Chandrasekar, US
GRAUPE, Michael, US
GUERRERO, Juan, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | OXAZEPINES AS ION CHANNEL MODULATORS |
| OXAZEPINES AS ION CHANNEL MODULATORS |